scholarly article | Q13442814 |
P356 | DOI | 10.1191/096120399678847344 |
P698 | PubMed publication ID | 10025594 |
P50 | author | Angela Tincani | Q73304219 |
Roberto Gerli | Q73737873 | ||
P2093 | author name string | F Fazio | |
A A Manfredi | |||
R Cattaneo | |||
A Campana | |||
C Rugarli | |||
M G Sabbadini | |||
M Piccirilli | |||
C Messa | |||
A Padovani | |||
R Scorza | |||
E Bozzolo | |||
R Quartesan | |||
A Passaleva | |||
A Farsi | |||
L Origgi | |||
O Gambini | |||
L Ferrario | |||
M Vanoli | |||
R Gasparotti | |||
D Croce | |||
E Emmi | |||
G Anzola | |||
L Vanzulli | |||
P2860 | cites work | “Mini-mental state” | Q25938989 |
Magnetic resonance and computed tomographic imaging in the evaluation of acute neuropsychiatric disease in systemic lupus erythematosus | Q33562233 | ||
Controversies in lupus: nervous system involvement | Q33567067 | ||
Brain single-photon emission tomography with 99mTc-HMPAO in neuropsychiatric systemic lupus erythematosus: relations with EEG and MRI findings and clinical manifestations | Q34307190 | ||
The neuropsychiatric manifestations of systemic lupus erythematosus: an overview | Q36462124 | ||
Cognitive deficit associated with rheumatic diseases: neuropsychological perspectives | Q40422622 | ||
Clinical brain radionuclide imaging studies | Q40435808 | ||
Psychiatric disorder and cognitive impairment in systemic lupus erythematosus | Q41120214 | ||
Recent developments in the understanding of antinuclear autoantibodies | Q41258667 | ||
The American Rheumatism Association, 1990. Presidential Address to the American Rheumatism Association, June 4, 1981. | Q41463994 | ||
Non-organic non-psychotic psychopathology (NONPP) in patients with systemic lupus erythematosus | Q41924726 | ||
Magnetic resonance imaging in systemic lupus erythematosus patients without a history of neuropsychiatric lupus erythematosus | Q43550890 | ||
Magnetic resonance imaging of the brain in neuropsychiatric systemic lupus erythematosus | Q46909297 | ||
Magnetic resonance imaging abnormalities and cognitive deficits in systemic lupus erythematosus patients without overt central nervous system disease | Q48562857 | ||
Magnetic resonance imaging of the brain and cerebral proton spectroscopy in patients with systemic lupus erythematosus | Q48820031 | ||
White matter hyperintensities in dementia of Alzheimer's type and in healthy subjects without cerebrovascular risk factors. A magnetic resonance imaging study | Q48846022 | ||
Accuracy of 133-xenon regional cerebral blood flow and quantitative electroencephalography in systemic lupus erythematosus | Q49026833 | ||
Corticosteroids and neuropsychological functioning in patients with systemic lupus erythematosus. | Q51131677 | ||
The psychosocial impact of systemic lupus erythematosus and rheumatoid arthritis. | Q51236322 | ||
Patterns of cognitive impairment in patients with systemic lupus erythematosus. | Q52062051 | ||
A Controlled study of the prevalence of cognitive dysfunction in randomly selected patients with systemic lupus erythematosus | Q57740739 | ||
P433 | issue | 1 | |
P921 | main subject | systemic lupus erythematosus | Q1485 |
P304 | page(s) | 11-19 | |
P577 | publication date | 1999-01-01 | |
P1433 | published in | Lupus | Q6704846 |
P1476 | title | Central nervous system involvement in systemic lupus erythematosus patients without overt neuropsychiatric manifestations | |
P478 | volume | 8 |
Q35625245 | A psychiatric perspective on the therapy of psychosis in systemic lupus erythematosus |
Q33608727 | Anti-alpha-internexin autoantibody from neuropsychiatric lupus induce cognitive damage via inhibiting axonal elongation and promote neuron apoptosis |
Q37613091 | Brain magnetic resonance imaging in newly diagnosed systemic lupus erythematosus |
Q42592241 | Cerebral angioedema associated with enalapril |
Q33332894 | Cerebral blood flow and glucose metabolism in multi-infarct-dementia related to primary antiphospholipid antibody syndrome |
Q44687451 | Cerebral hypoperfusion detected by SPECT in patients with systemic lupus erythematosus is related to clinical activity and cumulative tissue damage |
Q88094564 | Cognitive Impairment in Patients With Neuropsychiatric and Non-neuropsychiatric Systemic Lupus Erythematosus: A Systematic Review and Meta-analysis |
Q35625220 | Cognitive dysfunction and antiphospholipid antibodies in systemic lupus erythematosus |
Q33526071 | Diagnostic reliability of magnetic resonance imaging for central nervous system syndromes in systemic lupus erythematosus: a prospective cohort study |
Q50633207 | Electrophysiological Study on Cognitive Function in Systemic Lupus Erythematosus Patients With Previous Neuropsychiatric Involvement. |
Q33217667 | Elevated immunoglobulin levels in the cerebrospinal fluid from lupus-prone mice |
Q42282494 | Enlarged perivascular spaces are associated with the disease activity in systemic lupus erythematosus |
Q34746630 | Estrogen receptor alpha deficiency protects against development of cognitive impairment in murine lupus. |
Q53576675 | Evaluation of average amount of cerebral blood flow measured by brain perfusion index in patients with neuropsychiatric systemic lupus erythematosus. |
Q37032127 | Integrative neuroscience approach to neuropsychiatric lupus |
Q35185887 | Intractable headaches, ischemic stroke, and seizures are linked to the presence of anti-β2GPI antibodies in patients with systemic lupus erythematosus |
Q44752066 | Learning and memory-related brain activity dynamics are altered in systemic lupus erythematosus: a functional magnetic resonance imaging study. |
Q40416808 | Major life stress, coping styles, and social support in relation to psychological distress in patients with systemic lupus erythematosus |
Q43060467 | Microembolic signals in patients with systemic lupus erythematosus. |
Q34054877 | Neurocognitive impairment in children and adolescents with systemic lupus erythematosus |
Q35199278 | Neuroimaging evidence of white matter inflammation in newly diagnosed systemic lupus erythematosus |
Q73239513 | Neuropsychiatric Systemic Lupus Erythematosus |
Q34749154 | Neuropsychiatric involvement in systemic lupus erythematosus |
Q59924786 | Neuropsychiatric systemic lupus erythematosus |
Q36392300 | Neuropsychological patterns in systemic lupus erythematosus patients with depression |
Q33574487 | Pathogenesis, diagnosis and management of neuropsychiatric SLE manifestations |
Q35861313 | Physical activity, obesity, and cognitive impairment among women with systemic lupus erythematosus |
Q38584620 | Prevalence and correlates of suicidal thoughts in patients with neuropsychiatric lupus |
Q51069301 | Prevalence and pattern of cognitive impairment in systemic lupus erythematosus patients with and without overt neuropsychiatric manifestations. |
Q47802635 | Prevalence and severity of depression and anxiety in patients with systemic lupus erythematosus: An epidemiologic study in Iranian patients |
Q36896792 | Proposed response criteria for neurocognitive impairment in systemic lupus erythematosus clinical trials |
Q36052684 | Retinal nerve fiber layer and macular thinning in systemic lupus erythematosus: an optical coherence tomography study comparing SLE and neuropsychiatric SLE. |
Q33941483 | Serum S100B levels in patients with lupus erythematosus: preliminary observation |
Q57647177 | Silent cerebral MRI findings in lupus nephritis patients: Is it clinically significant? |
Q50913353 | Stress as a predictor of cognitive functioning in lupus. |
Q39596714 | Sustained normalization of cerebral blood-flow after iloprost therapy in a patient with neuropsychiatric systemic lupus erythematosus |
Q35625216 | The ACR nomenclature for CNS lupus revisited. |
Search more.